000 01319 a2200397 4500
005 20250511201622.0
264 0 _c19910712
008 199107s 0 0 eng d
022 _a0959-8138
024 7 _a10.1136/bmj.302.6785.1133
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSheldon, T A
245 0 0 _aAppraisal of a new scheme for prenatal screening for Down's syndrome.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cMay 1991
300 _a1133-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aChorionic Gonadotropin
_xblood
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDiagnostic Tests, Routine
_xeconomics
650 0 4 _aDown Syndrome
_xdiagnosis
650 0 4 _aEstriol
_xblood
650 0 4 _aFemale
650 0 4 _aFetal Diseases
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aMaternal Age
650 0 4 _aPredictive Value of Tests
650 0 4 _aPregnancy
_xblood
650 0 4 _aPregnant People
650 0 4 _aPrenatal Diagnosis
_xeconomics
650 0 4 _aRisk Factors
650 0 4 _aalpha-Fetoproteins
_xmetabolism
700 1 _aSimpson, J
773 0 _tBMJ (Clinical research ed.)
_gvol. 302
_gno. 6785
_gp. 1133-6
856 4 0 _uhttps://doi.org/10.1136/bmj.302.6785.1133
_zAvailable from publisher's website
999 _c1716923
_d1716923